Niraparib
Product Description
Shandong Boyuan Pharmaceutical Co., Ltd.
-
Country/Region:China
-
On CPHI since:2025
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
Categories
Specifications
Shandong Boyuan Pharmaceutical Co., Ltd.
-
Country/Region:China
-
On CPHI since:2025
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
More Products from Shandong Boyuan Pharmaceutical Co., Ltd. (99)
-
Product Vonoprazan Fumarate
Antiacid API
NMPA-I -
Product Upadacitinib Hemihydrate
Selective Immunosuppressants -
Product Crisaborole
Anti-dermatitis API
DMF -
Product Apremilast
Antipsoriatic API -
Product Butenafine Hydrochloride
Antifungal API -
Product Empagliflozin
Anti-diabetic API
NMPA-I/PMDA-under review -
Product Hydroxyurea
Antitumor API -
Product (6S)-2,6-Diamino-4,5,6,7-tetrahydro-benzothiazole
Pramipexole Intermediate -
Product (R)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethan-1-ol
Cenobamate Intermediate -
Product (S)-2-Benzylsuccinic Acid
Mitiglinide Calcium Intermediate -
Product (S)-N-(2',6'-Dimethylphenyl)-2-Piperidinecarboxamide
Ropivacaine Intermediate -
Product (S)-N-Glycidylphthalimide
Rivaroxaban Intermediate